Diffregen

We are developing novel immune activating leukemia therapeutics.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Philadelphia, PA, US
  • Currency USD
  • Founded February 2017
  • Employees 1
  • Incorporation Type C-corp
  • Website diffregen.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free